Search research articles
Contact Us
Filters
Showing results (91-100 of 265) with videos related to
Page
of 27
Sort By:
American Heart Journal
|
May 17, 2011
Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome
C Michael Gibson, Jessica L Mega, Paul Burton, et al.
Heart Rhythm
|
January 8, 2017
Extracranial arterial and venous thromboembolism in patients with atrial fibrillation: A meta-analysis of randomized controlled trials
Kang-Ling Wang, Harry R Büller, Shinya Goto, et al.
Clinical and Translational Science
|
August 7, 2022
Effect of CSL112 (apolipoprotein A-I [human]) on cholesterol efflux capacity in Japanese subjects: Findings from a phase I study and a cross-study comparison
Bo Zheng, Shinya Goto, Regina Clementi, et al.
European Journal of Preventive Cardiology
|
April 1, 2011
Relation between body mass index, waist circumference, and cardiovascular outcomes in 19,579 diabetic patients with established vascular disease: the REACH Registry
Jean Dallongeville, Deepak L Bhatt, P H Gabriel Steg, et al.
Plos One
|
March 9, 2022
Estradiol-induced immune suppression via prostaglandin E2 during parturition in bovine leukemia virus-infected cattle
Yamato Sajiki, Satoru Konnai, Tomohiro Okagawa, et al.
Veterinary Research
|
June 20, 2018
Cooperation of PD-1 and LAG-3 in the exhaustion of CD4<sup>+</sup> and CD8<sup>+</sup> T cells during bovine leukemia virus infection
Tomohiro Okagawa, Satoru Konnai, Asami Nishimori, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
May 4, 2010
Risk factor profiles of stroke, myocardial infarction, and atrial fibrillation: a Japanese Multicenter Cooperative Registry
Shinichiro Uchiyama, Yoshisato Shibata, Takayuki Hirabayashi, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
June 25, 2017
Once- or twice-daily non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of randomized controlled trials
Kang-Ling Wang, Chun-Chih Chiu, Doreen Su-Yin Tan, et al.
Journal of the American College of Cardiology
|
December 4, 2014
New ischemic stroke and outcomes with vorapaxar versus placebo: results from the TRA 2 °P-TIMI 50 trial
Marc P Bonaca, Benjamin M Scirica, Eugene Braunwald, et al.
The American Journal of Cardiology
|
February 27, 2010
Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)
Michel Krempf, Klaus G Parhofer, Ph Gabriel Steg, et al.
Page
of 27
Search research articles
Search
Showing results (91-100 of 265) with videos related to
Sort By:
Page
of 27
American Heart Journal
|
May 17, 2011
Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome
C Michael Gibson, Jessica L Mega, Paul Burton, et al.
Heart Rhythm
|
January 8, 2017
Extracranial arterial and venous thromboembolism in patients with atrial fibrillation: A meta-analysis of randomized controlled trials
Kang-Ling Wang, Harry R Büller, Shinya Goto, et al.
Clinical and Translational Science
|
August 7, 2022
Effect of CSL112 (apolipoprotein A-I [human]) on cholesterol efflux capacity in Japanese subjects: Findings from a phase I study and a cross-study comparison
Bo Zheng, Shinya Goto, Regina Clementi, et al.
European Journal of Preventive Cardiology
|
April 1, 2011
Relation between body mass index, waist circumference, and cardiovascular outcomes in 19,579 diabetic patients with established vascular disease: the REACH Registry
Jean Dallongeville, Deepak L Bhatt, P H Gabriel Steg, et al.
Plos One
|
March 9, 2022
Estradiol-induced immune suppression via prostaglandin E2 during parturition in bovine leukemia virus-infected cattle
Yamato Sajiki, Satoru Konnai, Tomohiro Okagawa, et al.
Veterinary Research
|
June 20, 2018
Cooperation of PD-1 and LAG-3 in the exhaustion of CD4<sup>+</sup> and CD8<sup>+</sup> T cells during bovine leukemia virus infection
Tomohiro Okagawa, Satoru Konnai, Asami Nishimori, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
May 4, 2010
Risk factor profiles of stroke, myocardial infarction, and atrial fibrillation: a Japanese Multicenter Cooperative Registry
Shinichiro Uchiyama, Yoshisato Shibata, Takayuki Hirabayashi, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
June 25, 2017
Once- or twice-daily non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of randomized controlled trials
Kang-Ling Wang, Chun-Chih Chiu, Doreen Su-Yin Tan, et al.
Journal of the American College of Cardiology
|
December 4, 2014
New ischemic stroke and outcomes with vorapaxar versus placebo: results from the TRA 2 °P-TIMI 50 trial
Marc P Bonaca, Benjamin M Scirica, Eugene Braunwald, et al.
The American Journal of Cardiology
|
February 27, 2010
Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)
Michel Krempf, Klaus G Parhofer, Ph Gabriel Steg, et al.
Page
of 27